LONDON - Scientists at Oxford believe their Covid-19 vaccine triggers a response that may offer a “double defence” against the virus. Phase I human trials of the world-leading vaccine have shown that it generates an immune response against the disease. “So far, so good,” said a source. “It’s an important moment. But we still have a long way to go.”